National Cancer Institute NCI Cancer Bulletin: A Trusted Source for Cancer Research News
June 26, 2012 • Volume 9 / Number 13


NCI Advisory Boards Hold Joint Meeting This Week

NCI’s Board of Scientific Advisors (BSA) and the National Cancer Advisory Board (NCAB) held a joint meeting June 24–25 on the NIH campus in Bethesda, MD.

Drs. Harold Varmus, Doug Lowy, and James Doroshow opened the meeting with the NCI Director’s Report. Their presentation included a discussion on NCI’s Provocative Questions Project, as well as the absolute risk reduction in the National Lung Screening Trial (NLST). (See the NLST Patient and Physician Guide.)

Attendees then heard presentations on a number of topics, including a report on the President’s Cancer Panel, the Frederick National Laboratory for Cancer Research strategic plan, highlights of efforts to improve the efficiency of NCI-sponsored clinical trials, and an update on the National Cancer Informatics Program.

The board members also recognized several departing BSA and NCAB members.

The agenda is available online, and an archived videocast of the meeting will be posted in a few days.

William Dahut Named Deputy Director of NCI's Center for Cancer Research

Dr. William Dahut has been named deputy director of NCI’s Center for Cancer Research (CCR). In this role, he will provide administrative and scientific oversight to a group of CCR laboratories and branches. He will also advise the CCR director and scientific director for clinical research on strategy, priority setting, resource allocation, and policy development.

Dr. William DahutDr. William Dahut

After joining NCI’s Medicine Branch in 1998 as head of the prostate cancer clinic, Dr. Dahut later became chief of the Genitourinary/Gynecological Clinical Research Section in what is now the Medical Oncology Branch.

Dr. Dahut will continue his role as clinical director of CCR, a position he has filled since 2009. In that role, Dr. Dahut oversees CCR’s clinical operations, including patient recruitment, clinical protocol review, management of inpatient units and outpatient clinics, human subjects protection, quality of patient care, and data management support.

Dr. Dahut’s primary research interest is the development of novel treatments for adenocarcinoma of the prostate.

Research to Reality Cyber-Seminar: How to Measure Health Disparities

The July 10 NCI Research to Reality (R2R) cyber-seminar will explore efforts and tools to help researchers and practitioners monitor and evaluate community health disparities. The seminar will highlight the Health Disparities Calculator (HD*Calc), free statistical software from NCI designed to evaluate and monitor health disparities.

Drs. Nancy Breen and Eva Wong Drs. Nancy Breen and Eva Wong

Dr. Nancy Breen of NCI’s Health Services and Economics Branch and her colleagues will provide an overview and demonstration of the tool. Dr. Eva Wong of the Seattle and King County (WA) Department of Public Health will discuss how Seattle/King staff have used the tool to evaluate health disparities in their county and how it has helped them improve programs designed to address these disparities.

For more information and to register for this event, visit the R2R website, where you can watch presentations and join discussions. All R2R cyber-seminars are archived on the website a week after the presentation. 

For more information on the cyber-seminar series, please e-mail

NCI Community Health Expo Will Feature Genomics, Biospecimens Research

NCI’s Center to Reduce Cancer Health Disparities and Center for Cancer Genomics, in conjunction with several NCI-designated cancer centers and other national and community organizations, will hold a community health expo, “Our Families, Our Research, Our Future,” on Saturday, July 14, from 10:00 a.m. to 3:00 p.m. ET at the Civic Building in Silver Spring, MD.

The free event is open to the public and will feature a variety of interactive exhibits on healthy lifestyles, preventive cancer screening, and research.

Community Health Expo 2012 banner

A panel of researchers will discuss community participation in biospecimen and clinical research from 11:30 a.m. to 12:15 p.m. ET. The discussion will include an introduction to tissue donation and explain why biospecimens are important in cancer research, what happens to donated tissue, the benefits and risks involved in research participation, and how high-quality biospecimens help researchers reduce cancer health disparities.

Attendees will also have an opportunity to participate in hands-on activities that demonstrate basic concepts of genome analysis and illustrate how genomics can reduce the burden of cancer.

More information about the event is available online.